Luca Bertamini
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 9
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 1
-
- Protein Degradation and Inhibitors 5
- Cancer therapeutics and mechanisms 2
- Co-authors
- Francesca Gay (7 shared papers)Mattia D’Agostino (4 shared papers)Mario Boccadoro (5 shared papers)Stefania Oliva (2 shared papers)Stefania Oliva (1 shared paper)Michèle Cavo (5 shared papers)Giovanni De Sabbata (2 shared papers)Elena Zamagni (2 shared papers)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (2 papers)Expert Opinion on Investigational Drugs (1 paper)Current Hematologic Malignancy Reports (1 paper)GeroScience (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
Luca Bertamini
15 papers receiving 176 citations
Peers
Comparison fields: 5 of 25
- Hematology 145
- Oncology 72
- Molecular Biology 101
- Genetics 11
- Aging 1
Countries citing papers authored by Luca Bertamini
This map shows the geographic impact of Luca Bertamini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Bertamini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Bertamini more than expected).
Fields of papers citing papers by Luca Bertamini
This network shows the impact of papers produced by Luca Bertamini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Bertamini. The network helps show where Luca Bertamini may publish in the future.
Co-authors
The 25 scholars most cited alongside Luca Bertamini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 38 | |
| 2 | 2020 | 32 | |
| 3 | 2019 | 25 | |
| 4 | 2021 | 19 | |
| 5 | 2018 | 16 | |
| 6 | 2022 | 14 | |
| 7 | 2020 | 12 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 3 | |
| 11 | 2017 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 1 |
About Luca Bertamini
Luca Bertamini is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 15 papers that have together received 176 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers), Protein Degradation and Inhibitors (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Cancer therapeutics and mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Treatment and Pharmacology (2 papers) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (145 citations), Oncology (72 citations), Molecular Biology (101 citations), Genetics (11 citations) and Aging (1 citation). Luca Bertamini has collaborated with scholars based in Italy and United States. Frequent co-authors include Francesca Gay, Mattia D’Agostino, Mario Boccadoro, Stefania Oliva, Stefania Oliva, Michèle Cavo, Giovanni De Sabbata, Elena Zamagni, Massimo Offidani and Renato Zambello. Their work appears in journals such as Blood, Journal of Clinical Oncology, Expert Opinion on Investigational Drugs, Current Hematologic Malignancy Reports and GeroScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.